Chemoinformaics analysis of (+)-(E)-CAFFEOYL-L-MALIC-ACID
| Molecular Weight | 296.231 | nRot | 6 |
| Heavy Atom Molecular Weight | 284.135 | nRig | 10 |
| Exact Molecular Weight | 296.053 | nRing | 1 |
| Solubility: LogS | -1.214 | nHRing | 0 |
| Solubility: LogP | 0.878 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 36.1275 |
| nHD | 4 | BPOL | 16.3785 |
| QED | 0.339 |
| Synth | 2.853 |
| Natural Product Likeliness | 1.378 |
| NR-PPAR-gamma | 0.782 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.013 |
| HIA | 0.169 |
| CACO-2 | -6.132 |
| MDCK | 0.0000653 |
| BBB | 0.142 |
| PPB | 0.880778 |
| VDSS | 0.284 |
| FU | 0.088833 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.037 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.039 |
| CYP3a4-sub | 0.006 |
| CL | 8.791 |
| T12 | 0.953 |
| hERG | 0.006 |
| Ames | 0.008 |
| ROA | 0.153 |
| SkinSen | 0.553 |
| Carcinogencity | 0.312 |
| EI | 0.375 |
| Respiratory | 0.117 |
| NR-Aromatase | 0.037 |
| Antiviral | Yes |
| Prediction | 0.818351 |